The next stage of regenerative medicine



July 10, 2019

Animatus Biosciences joins MassChallenge’s global network of startups.

Houston, July 10, 2019 - Yesterday, Animatus Biosciences was selected to participate in the MassChallenge Texas in Houston 2019 accelerator program. Animatus was one of over 250 startups to apply for the accelerator located in Houston, Texas. Animatus will participate in the MassChallenge Texas in Houston 2019 accelerator program, where it will receive access to MassChallenge's global network, world-class mentoring from industry experts, tailored programming, free co-working space, and unrivalled access to corporate partners. The accelerator culminates in September 2019 at the MassChallenge Texas in Houston Closing Ceremony.

Animatus Biosciences is a biotechnology company focused on the development of advanced regenerative medicine technology using it’s proprietary platform of engineered, synthetic transcription factors.

About MassChallenge

MassChallenge is a global network of zero-equity startup accelerators. Headquartered in the United States with locations in Boston, Israel, Mexico, Rhode Island, Switzerland, and Texas, MassChallenge is committed to strengthening the global innovation ecosystem by supporting high-potential startups across all industries, from anywhere in the world. To date, 1,900 MassChallenge alumni have raised more than $4 billion in funding, generated more than $2 billion in revenue, and created over 120,000 total jobs. Learn more about MassChallenge at